OTCM
MNNLF
Market cap821mUSD
May 12, Last price
9.97
Name
Menicon Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Menicon Co., Ltd. is a company dedicated to the manufacturing and global distribution of contact lenses and their essential care solutions. The firm supplies its range of eye care products to a diverse network of outlets, including medical facilities like hospitals and ophthalmology clinics, as well as retail channels such as specialized contact lens stores, eyewear retailers, and pharmacies. With a substantial international presence, Menicon extends its reach to over 80 countries, encompassing major markets in the United States, Europe, Oceania, and Asia. This Japanese entity, which was founded in 1943, is based in Nagoya.
Key people
Hisashi Moriyama
Executive Officer, Deputy Chief Senior Director of Domestic Sales · since 2018
Wataru Ito
Executive Officer, Chief Senior Director of New Business · since 2018
Koji Kawaura
Executive Officer, Chief Senior Director of Production Development · since 2017
Hideki Koga
Executive Officer, Chief Senior Director of Overseas · since 2017
Yowa Miura
Executive Officer, Manager of Business Administration Office in Main Business Supervision Unit · since 2019
Stephen Donald Newman
Executive Officer, Director of Product Development Business · since 2019
Motonari Watanabe
Executive Officer, Chief Financial Officer, Chief Senior Director of Business · since 2019
Mori Fukinbara
Director · since 2015
Tokiyasu Tsuchida
Director · since 2019
Ryutaro Honda
Independent Director · since 2019
Yoshimi Horinishi
Independent Director · since 2016
Shingo Watanabe
Independent Director · since 2018
Headquarters & legal address
葵3丁目21番19号
愛知県 名古屋市中区 460-0006
JP
愛知県 名古屋市中区 460-0006
JP
Address
3-21-19, Aoi
Naka-ku, Nagoya Aichi 460-0006
JP
Naka-ku, Nagoya Aichi 460-0006
JP
Other language
Menicon Co.,Ltd.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||